Kirill Medvedev
banner
kirillemedvedev.bsky.social
Kirill Medvedev
@kirillemedvedev.bsky.social
Assistant Professor @ucf.bsky.social
https://medvedev-lab.cs.ucf.edu/
Alumni @utswtxid.bsky.social
Computational Biology | Bionformatics | Cancer Biology
Really excited to be part of these Research Talks at @ucf.bsky.social Will be sharing some stories 🙂: "From Protein Domains to Cancer Subtypes: Harnessing the Power of Classification Algorithms to Advance Biology" #UCF #computerscience #bioinformatics #computationalbiology
October 16, 2025 at 8:21 PM
DrugDomain 2.0 (drugdomain.cs.ucf.edu) paper is out @csbj.org: doi.org/10.1016/j.cs... The new version of DB is an updated comprehensive resource, that extends earlier releases by linking evolutionary domain classifications to ligand binding events across the entire Protein Data Bank #bioinformatics
September 16, 2025 at 9:14 PM
DrugDomain v2.0 is out - drugdomain.cs.ucf.edu The database reports the interactions of structural protein domains with a wide array of small organic (including drugs) and inorganic compounds, covering the full breadth of the Protein Data Bank. doi.org/10.1101/2025... #drugdiscovery #alphafold
July 7, 2025 at 9:45 PM
Thrilled to share that I'll be joining @ucf.bsky.social as an Assistant Professor.
Medvedev Lab (medvedev-lab.cs.ucf.edu) will open in August 2025. Our work will address critical biological questions in Structural and Cancer Biology. Stay tuned 😉
May 14, 2025 at 4:57 PM
We used AI to study how post-translational modifications (PTMs) affect drug binding and protein structure. Using AF3, RFAA and Chai-1, we generated > 14,000 models with > 6,000 of ligand-related PTMs. Paper is out in J. of Chemoinformatics rdcu.be/ekFlo #drugdiscovery #alphafold #bioinformatics #AI
May 5, 2025 at 4:05 PM
Excited to share my recent research related to interactions between small molecule drugs and protein domains. @biophysicalsoc.bsky.social #bps2025 #computationalbiology #bioinformatics #drugdiscovery
February 17, 2025 at 4:02 PM
📜 Our new preprint is out: www.biorxiv.org/content/10.1...

💡 We explored the role of post-translational modifications (PTMs) in modulating drug binding, with a focus on understanding the structural consequences of PTMs using advanced AI methods.
January 28, 2025 at 6:07 PM